Abstract: Individuals having tumors are treated with pharmaceutical compositions comprising expression vectors, preferably adenovirus or retroviruses, comprising nucleic acid molecules encoding soluble IGF-1R. Such vectors express soluble IGF-1R in tumor cells resulting in reversal of the transformed phenotype, induction of apoptosis, and inhibition of tumorigenesis.
Type:
Grant
Filed:
November 13, 1996
Date of Patent:
July 4, 2000
Assignee:
Thomas Jefferson University
Inventors:
Renato Baserga, Mariana Resnicoff, Consuelo D'Ambrosio, Andre Ferber
Abstract: Processes are provided for the adhering together of articles employing vitrifiable adhesives. According to a preferred embodiment, two or more articles are contacted with a polymerizable adhesive comprising a particulate, inorganic filler and a polymerizable resin comprising at least 0.25% by weight of the adhesive of a polymerizable silane. The adhesive is then polymerized and the polymerized adhesive heated to afford a vitrified bond.
Type:
Grant
Filed:
June 16, 1981
Date of Patent:
December 27, 1983
Assignee:
Dentsply Research & Development Corporation